Exhibit 2.3
AMENDED AND RESTATED WARRANT AGREEMENT
THIS AMENDED AND RESTATED WARRANT AGREEMENT (this “Agreement”), dated as of September 28, 2021, is entered into by and among (i) LumiraDx Limited, a Cayman Island exempted company limited by shares with company number 314391 (the “Company”); (ii) Continental Stock Transfer & Trust Company, a New York Limited Purpose Trust Company (the “Outgoing Warrant Agent”), (iii) Computershare Inc., a Delaware corporation (“Computershare”), and its wholly owned subsidiary, Computershare Trust Company, N.A., a federally chartered trust company (collectively, the “Successor Warrant Agent”, also referred to herein as the “Transfer Agent”); and (iv) CA Healthcare Acquisition Corp. (“CAH”), a Delaware corporation.
WHEREAS, CAH and the Outgoing Warrant Agent are parties to that certain Warrant Agreement, dated as of January 26, 2021, and filed with the Securities and Exchange Commission (the “SEC”) on February 1, 2021 (the “Prior Warrant Agreement”); and
WHEREAS, on January 29, 2021, CAH consummated its initial public offering (“Offering”) of 11,500,000 units (the “Units”), with each Unit consisting of one share of Class A common stock of CAH, par value $0.0001 per share (“CAH Common Stock”), and one-half of one warrant, where each warrant entitles the holder to purchase one share of CAH Common Stock at a price of $11.50 per share (the “Warrants”); and
WHEREAS, CAH filed with the SEC a registration statement on Form S-1, File No. 333-251969 (the “Registration Statement”) and prospectus (the “Prospectus”) dated January 26, 2021, for the registration, under the Securities Act of 1933, as amended (the “Securities Act”), of the Units, the Warrants and the CAH Common Stock included in the Units; and
WHEREAS, CAH, the Company and LumiraDx Merger Sub, Inc., a Delaware corporation (“Merger Sub”), are parties to that certain Agreement and Plan of Merger, dated as of April 6, 2021, as amended on August 19, 2021 and August 27, 2021 (the “Merger Agreement”), which, among other things, provides for the merger of Merger Sub with and into CAH with CAH surviving such merger as a wholly-owned subsidiary of the Company (the “Merger”), and, as a result of the Merger, among other things, all shares of CAH Common Stock issued and outstanding immediately prior to the Effective Time (as such term is defined in the Merger Agreement), after giving effect to the transactions set out in the Merger Agreement, shall be automatically canceled and extinguished in accordance with the terms of the Merger Agreement, in consideration for the right to receive one common share of the Company with a par value of US$ 0.0000028 (the “Common Shares”); and
WHEREAS, the Company desires that the Outgoing Warrant Agent resign from acting, and the Successor Warrant Agent be appointed to act, on behalf of the Company, and the Outgoing Warrant Agent is willing to so resign and the Successor Warrant Agent is willing to so act, in connection with the issuance, registration, transfer, exchange, redemption and exercise of the Warrants and accordingly the Successor Warrant Agent shall be vested with and shall assume all the authority, powers, rights, immunities, duties, and obligations of the Outgoing Warrant Agent with like effect as if it were originally named as the Warrant Agent hereunder.
WHEREAS, the Company desires to provide for the form and provisions of the Warrants, the terms upon which they shall be issued and exercised, and the respective rights, limitation of rights, and immunities of the Company, the Successor Warrant Agent, and the holders of the Warrants; and